65,437 trials
Kidney Transplant Failure and Rejection
Primary: Change in Controlled Oral Word Association Test (COWAT) — .44; -2.11; -0.88; -1.78 score on a scale
COVID-19 · SARS-CoV 2
Primary: Number of Participants With Clinical Improvement at Day 14 — 9; 7; 9 Participants
Hepatitis C, Chronic
Primary: HCV Treatment Completion — 22; 22 Participants
Autism · ASD
Primary: Empathic Accuracy Performance
Glioma
Primary: Overall Survival at 12 Months — 74; 92 percentage of participants — p=0.03
Biliary Tract Neoplasms · Cholangiocarcinoma · Bile Duct Cancer
Primary: Progression Free Survival (PFS) — 4.54 Months
Acute Coronary Syndrome
Primary: Number of Patients With Major Adverse Cardiac Event — 42; 0; 437; 123 Participants
Post-operative Dental Pain
Primary: Time to Confirmed Perceptible Pain Relief — NA; 15.7; 20.2; 23.2 minutes — p=<0.001
Mitral Regurgitation · Mitral Valve Regurgitation
Primary: Single Leaflet Device Attachment (SLDA) Rate — 1.21 percentage of SLDAs
Chronic Pain
Primary: To Compare the Percentage of Subjects Who Achieved Significant Pain Relief Between the 3 Treatment Groups as Measured by a Visual Analog Pain Scale at 60 Minutes A…
Postural Tachycardia Syndrome · Ehlers-Danlos Syndrome
Primary: Executive Function (Stroop Word-color Test) — 48; 49; 50; 58 Testing Scores
Acute Pancreatitis · Intestinal Bacteria Flora Disturbance · Intestinal Dysfunction
Primary: Number of Participants With Gastrointestinal Failure Score Equal 0 — 12; 14 Participants
Infertility
Primary: Patient Satisfaction — 4.92; 4.84 units on a scale — p=0.57
Inflammation · Fatigue
Primary: Central Nervous System (CNS) Glutamate Measured by Magnetic Resonance Spectroscopy (MRS) — 1.26; 1.2; 1.26; 1.27 Glu/Cr
SARS-CoV 2 · ARDS
Primary: Change in Arterial Blood Oxygen Content to Fraction of Inspired Oxygen Ratio (PaO2/FiO2) — 10.7; 21.4; 61.1; 11.8 mmHg